DHFR and cancer: This mechanism has been demonstrated in HeLa cells with ecDNAs carrying the dihydrofolate reductase gene (DHFR), in which CRISPR-Cas9-linearized ecDNAs are found to integrate into the CRISPR cutting sites on the chromosome.22 Current evidence suggests that the outcome of ecDNA reintegration may be beneficial to cancer.